Abstract
Objective
We describe a case of Cushing’s syndrome due to ectopic ACTH secretion, where the only potential source on conventional imaging was a tiny benign-appearing lung nodule, which failed to take up radiolabelled octreotide.
Design and methods
To determine whether the patient might respond to therapeutic administration of octreotide, a test dose was given.
Results
Compared to ACTH and cortisol levels on a control day, the levels following the test dose of octreotide were lower. Subsequent therapeutic administration of subcutaneous octreotide normalised urine free cortisol, with symptomatic improvement, pending evaluation for surgery. Eventual resection of the lung nodule resulted in cure of hypercortisolism. Histological examination of the resected specimen confirmed bronchial carcinoid staining positive for ACTH.
Conclusions
This is one of the few cases described where ectopic ACTH secretion secondary to bronchial carcinoid responded to somatostatin analogue therapy. The case was also unusual in that the tumour responded despite not taking up radiolabelled octreotide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kaye TB, Krapo L (1990) The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434–444
Limper AH, Carpenter PC, Scheithauer B Staats BA (1992) The Cushing syndrome induced by bronchial carcinoid tumour. Ann Intern Med 117:209–214
Wajchenberg B, BB Mendonca, Liberman B et al (1994) Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15(6):752–787
Ilias I, Torpy D, Pacak K et al (2005) Cushing’s syndrome due to ectopic corticotrophin secretion: Twenty years at the National Institutes of Health. J Clin Endocrinol Metab 90(8):4955–4962
Loli P, Vignati P, Grossrubatscher E et al (2003) Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. J Clin Endocrinol Metab 88(3):1029–1035
Krenning EP, Kwekkeboom DJ, Bakker WH et al (1993) Somatostatin receptor scintigraphy with [11In-DTPA-D-Phe1]- and [123Tyr3]-octreotide: the Rotterdam experience with more than 1,000 patients. Eur J Nucl Med 20:716–731
Torpy DJ, Chen CC, Mullen N et al (1999) Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 84(4):1186–1192
Tsagarakis S, Christoforaki M, Giannopoulou H et al (2003) A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing’s syndrome. J Clin Endocrinol Metab 88(10):4754–4758
Bertagna X, Favrod-Coune C, Escourolle H et al (1989) Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. J Clin Endocrinol Metab 68(5):988–991
Hearn PR, Reynolds CL, Johansen K, Woodhouse NJ (1988) Lung carcinoid with Cushing’s syndrome: control of serum ACTH and cortisol levels using SMS 201–995 (sandostatin). Clin Endocrinol (Oxf) 28(2):181–185
Lamberts SW, Hofland LJ, van Koetsveld PM et al (1990) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab 71(3):566–574
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McDermott, J.H., Thabit, H., Hickey, N. et al. ACTH-secreting bronchial carcinoid: a diagnostic and therapeutic challenge. Ir J Med Sci 177, 269–272 (2008). https://doi.org/10.1007/s11845-008-0171-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-008-0171-x